Clinical Trial Update: Pharmacokinetics of DMF and the Effects of DMF on Exploratory Biomarkers [Phase 4]

View source ↗

Summary

Phase 4 study investigating pharmacokinetics of dimethyl fumarate and its effects on exploratory biomarkers in multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Tecfidera (dimethyl fumarate)

Snippet

Sponsor: Multiple Sclerosis Center of Northeastern New York | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED